Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.10.30
2023 THIRD QUARTERLY REPORT
2023.10.30
ag真人平台官方：2023年三季度报告
2023.09.28
Notification of publication of Corporate Communication
2023.09.28
2023 Interim Report
2023.08.30
ag真人平台官方：2023年半年度报告
2023.08.30
ag真人平台官方：2023年半年度报告摘要
2023.08.30
ag真人平台官方：独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和...
2023.08.30
ag真人平台官方：关于控股股东承诺不减持公司股份的公告
2023.08.30
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
2023.08.21
CHANGE OF FINANCIAL CONTROLLER
第一页
上一页
16
17
18
19
20
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
